Inhibits lysosomal acidification and prevents macrophage antigen presentation Inhibits formation of the NLRP3 inflammasome and thus release of IL-1β Reduces inflammation in models of multiple sclerosis, type 1 diabetes, and allergic asthma. Here, IL1B is linked to type 1 diabetes mellitus.